Lifeboat Foundation

Modifications to chromosomes in “engram” neurons control the encoding and retrieval of memories.

When the brain forms a memory of a new experience, neurons called engram cells encode the details of the memory and are later reactivated whenever we recall it. A new MIT study reveals that this process is controlled by large-scale remodeling of cells’ chromatin.

This remodeling, which allows specific genes involved in storing memories to become more active, takes place in multiple stages spread out over several days. Changes to the density and arrangement of chromatin, a highly compressed structure consisting of DNA and proteins called histones, can control how active specific genes are within a given cell.

Analysis revealed that variants in the HMGCR gene region, which represent proxies for statin treatment, were associated with overall cancer risk, suggesting that statins could lower overall cancer risk.

Cholesterol-lowering drugs called statins may reduce cancer risk in humans through a pathway unrelated to cholesterol, says a study published today in eLife.

Statins reduce levels of LDL-cholesterol, the so-called ‘bad’ cholesterol, by inhibiting an enzyme called HMG-CoA-reductase (HMGCR). Clinical trials have previously demonstrated convincing evidence that statins reduce the risk of heart attacks and other cardiovascular diseases. But evidence for the potential effect of statins to reduce the risk of cancer is less clear.

Continue reading “Statins may reduce cancer risk through mechanisms separate to cholesterol” »

When it comes to vitamin D, most adults exhibit either frank deficiency, which results in clear clinical symptoms, or insufficiency, which often goes undetected. But how that insufficiency impacts physical health and the vulnerability of older adults to frailty as they age has been difficult to determine.

Now a University at Buffalo study of 24–28–month-old mice, the equivalent of 65-to-80-year-old adults, has found that frailty can be slowed with what might be considered “over” supplementation with vitamin D, referred to as “hypersufficiency.”

Published Sept. 30 in Nutrients, the research builds on previous work that Kenneth L. Seldeen, Ph.D., first author and research assistant professor in the Department of Medicine in the Jacobs School of Medicine and Biomedical Sciences at UB, has been conducting for more than a decade with colleague Bruce R. Troen, MD, professor of medicine and chief of the Division of Geriatrics and Palliative Medicine and director of the Center for Successful Aging, both in the Jacobs School.

Gets advanced, but some might like.

A research team from Cologne has discovered that a change in the DNA structure—more precisely in the chromatin—plays a decisive role in the recovery phase after DNA damage. The key is a double occupation by two methyl groups on the DNA packaging protein histone H3 (H3K4me2). The discovery was made by scientists under the direction of Prof. Björn Schumacher of the Cluster of Excellence for Aging Research CECAD, the Center for Molecular Medicine Cologne (CMMC), and the Institute for Genome Stability in Aging and Disease at the University of Cologne. The specific change enables genes to be reactivated and proteins to be produced after damage: The cells regain their balance and the organism recovers. The protective role of H3K4me2 was identified in experiments with the nematode Caenorhabditis elegans. The study has now been published in the journal Nature Structural & Molecular Biology.

The genome in every human cell is damaged on a daily basis, for example in the skin by UV radiation from the sun. Damage to the DNA causes diseases such as cancer, influences development, and accelerates aging. Congenital malfunctions in DNA repair can lead to extremely accelerated aging in rare hereditary diseases. Therefore, preservation and reconstruction processes are particularly important to ensure development and to maintain tissue function. DNA, which is rolled up on packaging proteins—the histones—like on cable drums, is regulated by methyl groups. Various proteins are responsible for placing methyl groups on histones or removing them. The number of groups on the packaging proteins affects the activity of genes and thus the protein production of the cell.

Continue reading “Research team discovers mechanism that restores cell function after genome damage” »

A research collaboration between Kumamoto University and Nagasaki University in Japan has found that components leaking from broken muscle fibers activate “satellite” muscle stem cells. While attempting to identify the proteins that activate satellite cells, they found that metabolic enzymes, such as GAPDH, rapidly activated dormant satellite cells and accelerated muscle injury regeneration. This is a highly rational and efficient regeneration mechanism in which the damaged muscle itself activates the satellite cells that begin the regeneration process.

Skeletal muscle is made up of bundles of contracting muscle fibers and each muscle fiber is surrounded by satellite cells —muscle stem cells that can produce new muscle fibers. Thanks to the work of these satellite cells, muscle fibers can be regenerated even after being bruised or torn during intense exercise. Satellite cells also play essential roles in muscle growth during developmental stages and muscle hypertrophy during strength training. However, in refractory muscle diseases like muscular dystrophy and age-related muscular fragility (sarcopenia), the number and function of satellite cells decreases. It is therefore important to understand the regulatory mechanism of satellite cells in muscle regeneration therapy.

In mature skeletal muscle, satellite cells are usually present in a dormant state. Upon stimulation after muscle injury, satellite cells are rapidly activated and proliferate repeatedly. During the subsequent myogenesis, they differentiate and regenerate muscle fibers by fusing with existing muscle fibers or with together. Of these three steps (satellite cell activation, proliferation, and muscle differentiation), little is known about how the first step, activation, is induced.

August was the second-highest month for sales ever.

Colorado has seen over $1.1 billion in marijuana sales since the COVID-19 pandemic began in this country, according to figures from the state Department of Revenue.

Legal marijuana sales topped $200 million in August for the second month in a row, reaching the second-highest monthly total since recreational sales started in 2014. Counting back to March of this year, when Colorado and the rest of the nation began shutting down over the pandemic, dispensaries have sold over $1.1 billion in marijuana products — and that’s not counting sales in September and October.

Continue reading “Colorado Marijuana Sales Top $1 Billion Since Pandemic Began” »

This will be the 13th New Shepard mission and the 7th consecutive flight for this particular vehicle (a record), demonstrating its operational reusability. N…

Blue Origin successfully completed the 13th New Shepard mission on October 13, 2020. New Shepard flew 12 commercial payloads to space on this mission, including the Deorbit, Descent, and Landing Sensor Demonstration with NASA’s Space Technology Mission Directorate under a Tipping Point partnership. This was the first payload to fly mounted on the exterior of a New Shepard booster rather than inside the capsule, opening the door to a wide range of future high-altitude sensing, sampling, and exposure payloads.

Continue reading “Replay — New Shepard Mission NS-13 Webcast” »

Eli Lilly said Wednesday a monoclonal antibody treatment is effective in reducing levels of the virus that causes Covid-19 in patients, and also appears to prevent patients from visiting the emergency room or hospital.

Lilly had previously released results for a similar treatment using one antibody, which experts viewed as promising. But the new results, of a combination of two antibodies, appear, based on limited data provided in a press release, to be more robust. The results also appear roughly similar to those Regeneron presented last week of its own cocktail of two monoclonal antibodies. Last Friday, President Trump was treated with the Regeneron monoclonal antibodies.

Monoclonal antibodies are synthetic versions of the antibodies that are one of the main weapons of the immune system. Researchers believed that injecting them into patients could help treat them.

There’s no need to fear arsenic poisoning if you grew up in the Argentinian Andes — hundreds of years of drinking arsenic-laced groundwater will have left you with a genetic tolerance for it.

Geneticists from Lund and Uppsala universities had noticed that certain plants and bacteria could live in environments with lots of arsenic, with natural selection favouring a gene known to improve their ability to metabolise the poison. Curious to see if humans could also gain some kind of arsenic immunity, they looked at a group of people who they knew would have been exposed to the poison over many generations — the indigenous peoples of the Argentinian part of the Andes. Sure enough, a higher-than average proportion of people they studied possessed the AS3MT gene, which lets them flush out toxins faster than “normal” people.

The genetic samples tested for the AS3MT gene came from 346 residents of the small, isolated town of San Antonio de los Cobres, located more than 3,700m above sea level in the Andes. Not only does the bedrock in the surrounding area contain a lot of arsenic which gets into the groundwater, but mining operations from the era of Spanish colonisation onwards have released even more arsenic — so both modern people and mummies dating back 7,000 years have had high levels of arsenic found in their hair and internal organs.